clinicaltrials.gov· Vertex Pharmaceuticals Incorporated · ClinicalTrials.gov·· 3 hours agoScore35
A Phase 3b Study of Participant Experience on Povetacicept Administered Via Autoinjector as Compared to Sibeprenlimab Administered Via Prefilled Syringe
In brief
A Phase 3b study of povetacicept in IgAN has been registered to compare the treatment experience of its autoinjector with sibeprenlimab delivered via prefilled syringe. The trial plans to enroll 40 participants and will also assess the safety and tolerability of povetacicept. NCT07890909 was first registered on 2026-10-22, is not yet recruiting, and is planned to start on 2026-10-23.
Source: clinicaltrials.gov · clinicaltrials.gov